Established in 2020, ROSEAId emerged from a significant collaboration with University of Texas Health, a premier US medical institution. ROSE AI our telepathology platform revolutionizes digital pathology leveraging our AI-driven, cloud-based technology, encompassing academia, research and clinical field requirements.

ROSEAID  the revolutionary platform that broadens the scope and expertise of a pathologist. The platform allows the medical team to collaborate and digitize their footprint ensuring the perpetuity of their skills. Essentially, creating a limitless pathology workspace, allowing pathologists to capture, share, and analyze critical insights in a life-saving manner, regardless of their location.